Prognostic Factors Associated with 2-year Mortality in Patients with Intermittent Claudication Treated with Endovascular Therapy for Femoropopliteal Lesions: Results from the Multicenter PROCYON Study
Dialysis, low BMI, CAD, and low ABI were risk factors for a worse 2-year prognosis in patients with intermittent claudication who underwent EVT for femoropopliteal lesions. Statins and cilostazol may improve the 2-year prognosis of patients with lower extremity artery disease.
Authors
- Kohei Yamaguchi
- Naoki Yoshioka (ORCID: https://orcid.org/0000-0003-3700-9570)
- Takashi Yanagiuchi (ORCID: https://orcid.org/0000-0001-5179-1277)
- Takahiro Tokuda
- Tatsuya Nakama (ORCID: https://orcid.org/0000-0001-9107-6438)
- Akiko Tanaka (ORCID: https://orcid.org/0000-0003-0238-1436)
- Tatsuro Takei (ORCID: https://orcid.org/0000-0001-8733-473X)
- Kenji Ogata (ORCID: https://orcid.org/0009-0004-7268-6491)
- Shunsuke Kojima
Institutions
- Rakuwakai Otowa Hospital (JP)
- Ogaki Municipal Hospital (JP)
- Nagoya Heart Center (JP)
- Saiseikai Yokohama Eastern Hospital (JP)
- Sendai Kousei Hospital (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2024-12-24
- DOI
- https://doi.org/10.5551/jat.65379
- Citations
- 3
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 1.72